Circulating Proteomics and Risk of Atrial Fibrillation: A Systematic Review of Cohort Studies
Journal of Cellular and Molecular Medicine · 2025-08 · 29 (15)
DOI: 10.1111/jcmm.70760 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 05.08.2025. Verfasst von Luxiang Shang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Chin…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Proteomics, Biomarkers, Blood Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Postdoctoral Innovation Program of Shandong Province.
Abstract (Originalsprache)
Atrial fibrillation (AF) is a common arrhythmia associated with significant morbidity and adverse outcomes. High‐throughput proteomics offers a promising approach for identifying circulating biomarkers to improve AF risk stratification. This systematic review evaluated cohort studies published from 2010 to 2024 that employed proteomic approaches to investigate associations between circulating proteins and AF incidence. Studies were screened using predefined criteria, and proteins significantly associated with AF in fully adjusted models were extracted. Bioinformatics analyses, including pathway enrichment and protein–protein interaction (PPI) network mapping, were conducted to characterise the implicated biological processes. Proteins reproducibly associated with AF across studies were further evaluated through drug target annotation and assessed for potential causal relationships using Mendelian randomisation (MR). In total, 111 proteins were identified across nine cohorts, with significant enrichment in pathways related to extracellular matrix organisation and cell adhesion. PPI analysis identified interleukin‐6, matrix metalloproteinase‐2 and C‐reactive protein as central network hubs. Thirteen proteins were reproducible across at least two studies, with NT‐proBNP consistently reported in eight cohorts, supporting its role as a robust and reliable biomarker of AF risk. Drug target analysis showed that four proteins—ANGPT‐2, adrenomedullin, GDF15 and PLAUR—are currently under clinical investigation. MR analysis did not confirm causal associations between these proteins and AF, suggesting they may reflect disease‐related processes rather than directly drive AF onset. This review highlights reproducible proteomic biomarkers and their functional networks in AF, providing a foundation for future studies focused on biomarker‐guided prevention and therapeutic development. Trial Registration: PROSPERO number: CRD420251063038
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
- Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
- Department of Pacing and Electrophysiology, Xinjiang Key Laboratory of Cardiac Electrophysiology and Remodeling, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
ORCID-Profile: Yinglong Hou
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Innovation Program of Shandong Province
- Jinan "20 New Universities" Research Funding Project
- Academic Promotion Program of Shandong First Medical University
Zitieren
APA
Shang, L., Wang, W., Liu, Y., Tang, B., & Hou, Y. (2025). Circulating Proteomics and Risk of Atrial Fibrillation: A Systematic Review of Cohort Studies. Journal of Cellular and Molecular Medicine, 29(15). https://doi.org/10.1111/jcmm.70760
Vancouver
Shang L, Wang W, Liu Y, Tang B, Hou Y. Circulating Proteomics and Risk of Atrial Fibrillation: A Systematic Review of Cohort Studies. Journal of Cellular and Molecular Medicine. 2025;29(15). doi:10.1111/jcmm.70760
BibTeX
@article{Shang2025,
author = {Shang, Luxiang and Wang, Weilin and Liu, Yiying and Tang, Baopeng and Hou, Yinglong},
title = {Circulating Proteomics and Risk of Atrial Fibrillation: A Systematic Review of Cohort Studies},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {15},
doi = {10.1111/jcmm.70760}
}
EUVIMED